| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Psychobiology Research Unit, Department of Psychology, Tel Aviv University, Tel Aviv, Israel
The sympathetic nervous system has been implicated in mediating stress-induced alterations in NK cell activity, particularly through stimulation of ß-adrenergic receptors. However, because catecholamines induce time-dependent alterations in the distribution of NK cells, the impact of ß-adrenergic stimulation on individual NK cell cytotoxicity is not clear, nor are its implications regarding host resistance to metastatic spread. To address these issues, we used the ß-adrenergic agonist, metaproterenol (MP), in F344 rats. The number of blood NK cells doubled within 10 min of MP administration and returned to baseline levels within 1 h. By this time, MP suppressed blood NK activity in a dose-dependent manner. Two ß-adrenergic antagonists, propranolol, which crosses the blood-brain barrier, and nadolol, which does not, blocked this suppression. Corresponding findings were obtained using an NK-sensitive tumor model, the MADB106. MP caused an up to 10 times increase in the number of tumor cells retained in the lungs 1 day after inoculation and a similar rise in the number of consequent lung metastases detected 3 wk later. These effects were dose dependent and nadolol reversible. NK cells appear to play a central role in mediating the tumor-enhancing effects of MP because their selective depletion nearly abolished this effect. Overall, our findings suggest that independent of the transitory increase in numbers of blood NK cells, in vivo ß-adrenergic stimulation suppresses NK activity in the rat. This suppression is induced peripherally and can compromise host resistance to NK-sensitive tumors. Homologies to studies in humans and clinical relevance are discussed.
This article has been cited by other articles:
|
|
 |
|
  M. Benish, I. Bartal, Y. Goldfarb, B. Levi, R. Avraham, A. Raz, and S. Ben-Eliyahu Perioperative Use of {beta}-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis Ann. Surg. Oncol., July 1, 2008; 15(7): 2042 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Shakhar, N. Abudarham, R. Melamed, Y. Schwartz, E. Rosenne, and S. Ben-Eliyahu Amelioration of Operation-Induced Suppression of Marginating Pulmonary NK Activity using Poly IC: A Potential Approach to Reduce Postoperative Metastasis Ann. Surg. Oncol., February 1, 2007; 14(2): 841 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shakhar, E. Rosenne, R. Loewenthal, G. Shakhar, H. Carp, and B.-E. Shamgar High NK cell activity in recurrent miscarriage: what are we really measuring? Hum. Reprod., September 1, 2006; 21(9): 2421 - 2425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Loop, T. Bross, M. Humar, A. Hoetzel, R. Schmidt, H. L. Pahl, K. K. Geiger, and B. H. J. Pannen Dobutamine Inhibits Phorbol-Myristate-Acetate-Induced Activation of Nuclear Factor-{kappa}B in Human T Lymphocytes In Vitro Anesth. Analg., November 1, 2004; 99(5): 1508 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Melamed, S. Bar-Yosef, G. Shakhar, K. Shakhar, and S. Ben-Eliyahu Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures Anesth. Analg., November 1, 2003; 97(5): 1331 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Yakar, R. Melamed, G. Shakhar, K. Shakhar, E. Rosenne, N. Abudarham, G. G. Page, and S. Ben-Eliyahu Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats Ann. Surg. Oncol., May 1, 2003; 10(4): 469 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Curtis and A. Punturieri Enhancing Antitumor Immunity Perioperatively: A Matter of Timing, Cooperation, and Specificity Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 541 - 545. [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Friedman and D. A. Lawrence Environmental Stress Mediates Changes in Neuroimmunological Interactions Toxicol. Sci., May 1, 2002; 67(1): 4 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi The Sympathetic Nerve---An Integrative Interface between Two Supersystems: The Brain and the Immune System Pharmacol. Rev., December 1, 2000; 52(4): 595 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jung and M. Irwin Reduction of Natural Killer Cytotoxic Activity in Major Depression: Interaction Between Depression and Cigarette Smoking Psychosom Med, May 1, 1999; 61(3): 263 - 270. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
